MX2009008059A - Agente para tratamiento de esclerosis multiple. - Google Patents

Agente para tratamiento de esclerosis multiple.

Info

Publication number
MX2009008059A
MX2009008059A MX2009008059A MX2009008059A MX2009008059A MX 2009008059 A MX2009008059 A MX 2009008059A MX 2009008059 A MX2009008059 A MX 2009008059A MX 2009008059 A MX2009008059 A MX 2009008059A MX 2009008059 A MX2009008059 A MX 2009008059A
Authority
MX
Mexico
Prior art keywords
multiple sclerosis
treatment
agent
prevention
disclosed
Prior art date
Application number
MX2009008059A
Other languages
English (en)
Inventor
Masaki Yamabi
Yuichiro Tabunoki
Toshiyuki Edano
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of MX2009008059A publication Critical patent/MX2009008059A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe un agente administrable oralmente para prevención y/o tratamiento de esclerosis múltiple, que es altamente eficaz para esclerosis múltiple y de completa seguridad; se divulga específicamente un agente para la prevención y/o tratamiento de esclerosis múltiple, que contiene 2-bencil-5-(4-clorofenil)-6-[4-( metilito)fenil]-2H-piridazin-3-ona o un solvato de éste como un ingrediente activo.
MX2009008059A 2007-01-29 2008-01-28 Agente para tratamiento de esclerosis multiple. MX2009008059A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007017328 2007-01-29
PCT/JP2008/000099 WO2008093495A1 (ja) 2007-01-29 2008-01-28 多発性硬化症治療剤

Publications (1)

Publication Number Publication Date
MX2009008059A true MX2009008059A (es) 2009-08-12

Family

ID=39673809

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008059A MX2009008059A (es) 2007-01-29 2008-01-28 Agente para tratamiento de esclerosis multiple.

Country Status (12)

Country Link
US (1) US20100075972A1 (es)
EP (1) EP2127653A1 (es)
JP (1) JPWO2008093495A1 (es)
KR (1) KR20090114371A (es)
CN (1) CN101600435A (es)
AU (1) AU2008211480A1 (es)
BR (1) BRPI0805841A2 (es)
CA (1) CA2669563A1 (es)
EA (1) EA200970720A1 (es)
MX (1) MX2009008059A (es)
TW (1) TW200838535A (es)
WO (1) WO2008093495A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00004955A (es) * 1997-11-19 2002-10-17 Kowa Co Derivados novedosos de piridazina y medicinas que los contienen como ingredientes activos.
IL154709A0 (en) * 2000-09-18 2003-10-31 Eisai Co Ltd Pyridazinone and triazinone derivatives and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CN101600435A (zh) 2009-12-09
JPWO2008093495A1 (ja) 2010-05-20
US20100075972A1 (en) 2010-03-25
WO2008093495A1 (ja) 2008-08-07
KR20090114371A (ko) 2009-11-03
AU2008211480A1 (en) 2008-08-07
EA200970720A1 (ru) 2009-12-30
CA2669563A1 (en) 2008-08-07
BRPI0805841A2 (pt) 2011-08-30
TW200838535A (en) 2008-10-01
EP2127653A1 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
GEP20146004B (en) Pyridazinone compounds
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
WO2008033562A3 (en) Kinase inhibitor compounds
UA108087C2 (uk) Тверді форми n-(4-(7-азабіцикло[2.2.1]гептан-7-іл)-2-(трифторметил)феніл)-4-оксо-5-(трифторметил)-1,4-дигідрохінолін-3-карбоксаміду
WO2010084115A3 (en) Antiviral agents
MX2009006535A (es) Derivados de indol-4-il-pirimidinil-2-il-amina y su uso como inhibidores de cinasa dependiente de ciclina.
MX2011007424A (es) Derivados de sulfonamida.
WO2007103694A3 (en) Triazine 11-beta hydroxysteroid dehydrogenase type i inhibitors
MY155255A (en) Spiro-oxindole compounds and their use as therapeutic agents
WO2007130655A3 (en) Phage derived antimicrobial activities
WO2008147864A3 (en) Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
MA32135B1 (fr) Inhibiteurs de pim kinase et leurs procedes d'utilisation
WO2008043071A3 (en) Use of spongilla spicules as a dermabrasion device or resurfacing modality
WO2012046030A3 (en) Phosphodiesterase inhibitors
WO2006078424A3 (en) Polyherbal compositions and methods for treating viral infections
IL205697A0 (en) 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazole-2-yl)benzenesulfon-amide derivatives, compositions comprising the same and uses thereof
WO2011113060A3 (en) Antiviral compounds and methods of use thereof
UA103181C2 (ru) Соединения, которые ингибируют дипептидилпептидазу-iv и фармацевтическая композиция, которая содержит их как активный агент
GEP201706656B (en) 2-thiopyrimidinones
WO2009041663A1 (ja) 皮膚疾患の予防及び／または治療剤
EP2033954A4 (en) COMPOUND 6- (4-OXOQUINOLIN-SUBSTITUTED BENZYL) AND USE THEREOF AS INHIBITOR OF HIV INTEGRASE
MX2011012614A (es) Compuestos de quetolida que tienen actividad antimicrobiana.
TN2011000204A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament